1. Home
  2. SEMR vs RAPP Comparison

SEMR vs RAPP Comparison

Compare SEMR & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEMR
  • RAPP
  • Stock Information
  • Founded
  • SEMR 2008
  • RAPP 2022
  • Country
  • SEMR United States
  • RAPP United States
  • Employees
  • SEMR N/A
  • RAPP N/A
  • Industry
  • SEMR EDP Services
  • RAPP
  • Sector
  • SEMR Technology
  • RAPP
  • Exchange
  • SEMR Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • SEMR 1.1B
  • RAPP 1.2B
  • IPO Year
  • SEMR 2021
  • RAPP 2024
  • Fundamental
  • Price
  • SEMR $7.01
  • RAPP $25.82
  • Analyst Decision
  • SEMR Buy
  • RAPP Strong Buy
  • Analyst Count
  • SEMR 6
  • RAPP 3
  • Target Price
  • SEMR $13.50
  • RAPP $35.33
  • AVG Volume (30 Days)
  • SEMR 1.2M
  • RAPP 384.2K
  • Earning Date
  • SEMR 11-05-2025
  • RAPP 11-07-2025
  • Dividend Yield
  • SEMR N/A
  • RAPP N/A
  • EPS Growth
  • SEMR N/A
  • RAPP N/A
  • EPS
  • SEMR N/A
  • RAPP N/A
  • Revenue
  • SEMR $413,962,000.00
  • RAPP N/A
  • Revenue This Year
  • SEMR $20.28
  • RAPP N/A
  • Revenue Next Year
  • SEMR $16.41
  • RAPP N/A
  • P/E Ratio
  • SEMR N/A
  • RAPP N/A
  • Revenue Growth
  • SEMR 22.16
  • RAPP N/A
  • 52 Week Low
  • SEMR $6.91
  • RAPP $6.43
  • 52 Week High
  • SEMR $18.74
  • RAPP $42.27
  • Technical
  • Relative Strength Index (RSI)
  • SEMR 42.22
  • RAPP 48.37
  • Support Level
  • SEMR $6.99
  • RAPP $25.17
  • Resistance Level
  • SEMR $7.33
  • RAPP $29.49
  • Average True Range (ATR)
  • SEMR 0.35
  • RAPP 1.85
  • MACD
  • SEMR -0.03
  • RAPP -0.21
  • Stochastic Oscillator
  • SEMR 25.98
  • RAPP 20.67

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: